Review



car t cells against cd19  (Novartis)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Novartis car t cells against cd19
    Car T Cells Against Cd19, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/car+t+cells+against+cd19/car+cd19+gegen+gerichtete+insbesondere+t+tisagenlecleucel+wie+zellen/us12590292-28-6-12
    Average 86 stars, based on 1 article reviews
    car t cells against cd19 - by Bioz Stars, 2026-09
    86/100 stars

    Images

    Related Articles

    Transplantation Assay:

    Article Title: Targeted T-cell therapy for treatment of multiple myeloma
    Article Snippet: .. Autologous transplantation followed by treatment with CAR T cells against CD19 (KymriahTM, Novartis) demonstrated activity in a patient with refractory multiple myeloma, leading to a complete remission lasting longer than previous remissions, but with subsequent relapse (Garfall et al.; Chimeric antigen receptor T cells against CD19 for multiple myeloma. ..

    Activity Assay:

    Article Title: Targeted T-cell therapy for treatment of multiple myeloma
    Article Snippet: .. Autologous transplantation followed by treatment with CAR T cells against CD19 (KymriahTM, Novartis) demonstrated activity in a patient with refractory multiple myeloma, leading to a complete remission lasting longer than previous remissions, but with subsequent relapse (Garfall et al.; Chimeric antigen receptor T cells against CD19 for multiple myeloma. ..



    Similar Products

    car t cells against cd19  (Novartis)
    86
    Novartis car t cells against cd19
    Car T Cells Against Cd19, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/car+t+cells+against+cd19/car+cd19+gegen+gerichtete+insbesondere+t+tisagenlecleucel+wie+zellen/us12590292-28-6-12
    Average 86 stars, based on 1 article reviews
    car t cells against cd19 - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    autologous anti cd19 car t cell therapies against b cell lymphoma  (Gilead Sciences)
    99
    Gilead Sciences autologous anti cd19 car t cell therapies against b cell lymphoma
    List of clinical trials employing non-classical/alternative chimeric antigen receptor (CAR) vehicles or combinations listed on www.clinicaltrials.gov .
    Autologous Anti Cd19 Car T Cell Therapies Against B Cell Lymphoma, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/car+t+cells+against+cd19/Yescarta/pmc07279007-40-19-32
    Average 99 stars, based on 1 article reviews
    autologous anti cd19 car t cell therapies against b cell lymphoma - by Bioz Stars, 2026-09
    99/100 stars
    		  Buy from Supplier
    car t cell reagents against cd19  (Novartis)
    90
    Novartis car t cell reagents against cd19
    List of clinical trials employing non-classical/alternative chimeric antigen receptor (CAR) vehicles or combinations listed on www.clinicaltrials.gov .
    Car T Cell Reagents Against Cd19, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/car+t+cells+against+cd19/anti+cd19+scfv+4+1bb+++cd3%CE%B6/pm29246759-387-1-29
    Average 90 stars, based on 1 article reviews
    car t cell reagents against cd19 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    List of clinical trials employing non-classical/alternative chimeric antigen receptor (CAR) vehicles or combinations listed on www.clinicaltrials.gov .

    Journal: International Journal of Molecular Sciences

    Article Title: CARs: Beyond T Cells and T Cell-Derived Signaling Domains

    doi: 10.3390/ijms21103525

    Figure Lengend Snippet: List of clinical trials employing non-classical/alternative chimeric antigen receptor (CAR) vehicles or combinations listed on www.clinicaltrials.gov .

    Article Snippet: The greatest success in the CAR field so far and a milestone in cellular therapy was achieved when two autologous anti-CD19-CAR T cell therapies against B cell lymphoma (Kymriah ® (Tisagenlecleucel) and Yescarta ® (axicabtagen-ciloleucel)) were approved by the Food and Drug Administration (FDA) [ ], reaching an astonishing remission rate of 80% [ ].

    Techniques: Construct

    List of clinical trials employing CAR-NK cells listed on www.clinicaltrials.gov .

    Journal: International Journal of Molecular Sciences

    Article Title: CARs: Beyond T Cells and T Cell-Derived Signaling Domains

    doi: 10.3390/ijms21103525

    Figure Lengend Snippet: List of clinical trials employing CAR-NK cells listed on www.clinicaltrials.gov .

    Article Snippet: The greatest success in the CAR field so far and a milestone in cellular therapy was achieved when two autologous anti-CD19-CAR T cell therapies against B cell lymphoma (Kymriah ® (Tisagenlecleucel) and Yescarta ® (axicabtagen-ciloleucel)) were approved by the Food and Drug Administration (FDA) [ ], reaching an astonishing remission rate of 80% [ ].

    Techniques: